| Code | 4651D | ||||||||||
| MA number | 44/0123/20-S | ||||||||||
| Product Form: | plv inu 1x100 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 01.06.2020 |
| Validity: | 01.06.2025 |
| MA renewed: | Renewal application submitted |
| SPC: |
SPC_Azacitidine Sandoz 25 mg_ml prášok na injekčnú suspenziu_02.2024.pdf
|
| PIL: |
PIL_Azacitidine Sandoz 25 mg_ml prášok na injekčnú suspenziu_02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 01.06.2020 |
